SAN FRANCISCO — A team of Cooley attorneys advised Gilead Sciences Inc. in its $225 million buy of Arresto Biosciences Inc., a privately owned Palo Alto biotech company.
The lawyers, all working from the firm’s Palo Alto office, included partners David Lipkin and Barbara Kosacz , and associates Lila Hope , Tali Sealman and Brandee Winikoff. Morgan, Lewis & Bockius partner S. James DiBernardo advised Gilead on employment and employee benefits matters. He was assisted by Morgan, Lewis associates Julie Davies and David Calder.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
